Search

  • HOME
  • Search
Editorial
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
Kee-Huat Chuah, Wah-Kheong Chan
Clin Mol Hepatol. 2023;29(2):401-403.   Published online February 28, 2023
View: 3612   Download: 75  Web of Science: 3  Crossref: 3
Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
Maamon Basheer, Mohamed Naffaa, Nimer Assy
Clin Mol Hepatol. 2023;29(2):398-400.   Published online February 13, 2023
View: 4220   Download: 148  Web of Science: 3  Crossref: 3
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
Lynna Alnimer, Mazen Noureddin
Clin Mol Hepatol. 2023;29(2):394-397.   Published online April 1, 2023
View: 3696   Download: 94  Web of Science: 1
Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
Joo Hyun Oh, Dong Hyun Sinn
Clin Mol Hepatol. 2023;29(2):367-370.   Published online March 20, 2023
View: 3320   Download: 70  Web of Science: 4  Crossref: 3
Review
1714
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Kuei-Chuan Lee, Pei-Shan Wu, Han-Chieh Lin
Clin Mol Hepatol. 2023;29(1):77-98.   Published online October 13, 2022
View: 13548   Download: 766  Web of Science: 74  Crossref: 84
Original Article
1688
Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways
Seung Min Lee, Dong Hee Koh, Dae Won Jun, Yoon Jin Roh, Hyeon Tae Kang, Ju Hee Oh, Hyun Sung Kim
Clin Mol Hepatol. 2022;28(4):827-840.   Published online June 22, 2022
View: 8878   Download: 435  Web of Science: 23  Crossref: 23
Editorial
1701
Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait
Carlos J. Pirola, Silvia Sookoian
Clin Mol Hepatol. 2022;28(4):806-809.   Published online August 19, 2022
View: 3267   Download: 73
Letter to the Editor
Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
Saori Takamura, Yuichi Teraki, Eri Katayama, Takumi Kawaguchi, Machiko Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Sumiko Nagoshi, Takekuni Nakama, Takuji Torimura
Clin Mol Hepatol. 2022;28(2):269-272.   Published online February 15, 2022
View: 6241   Download: 387  Web of Science: 14  Crossref: 13
Original Article
1642
U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
Huapeng Lin, Grace Lai-Hung Wong, Xinrong Zhang, Terry Cheuk-Fung Yip, Ken Liu, Yee Kit Tse, Vicki Wing-Ki Hui, Jimmy Che-To Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong
Clin Mol Hepatol. 2022;28(1):77-90.   Published online November 5, 2021
View: 7033   Download: 157  Web of Science: 18  Crossref: 17
1607
Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B
Lilian Yan Liang, Hye Won Lee, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip, Yee-Kit Tse, Vicki Wing-Ki Hui, Grace Chung-Yan Lui, Henry Lik-Yuen Chan, Grace Lai-Hung Wong
Clin Mol Hepatol. 2021;27(3):499-509.   Published online February 26, 2021
View: 5758   Download: 142  Web of Science: 16  Crossref: 16
Review
1578
Anti-fibrotic treatments for chronic liver diseases: The present and the future
Naoshi Odagiri, Tsutomu Matsubara, Misako Sato-Matsubara, Hideki Fujii, Masaru Enomoto, Norifumi Kawada
Clin Mol Hepatol. 2021;27(3):413-424.   Published online December 3, 2020
View: 15535   Download: 503  Web of Science: 29  Crossref: 31
Original Article
1581
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
Mi Young Jeon, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Clin Mol Hepatol. 2021;27(2):295-304.   Published online December 3, 2020
View: 6351   Download: 215  Web of Science: 20  Crossref: 25
Editorial
Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
Clin Mol Hepatol. 2021;27(2):273-277.   Published online February 1, 2021
View: 5329   Download: 142  Web of Science: 5  Crossref: 6
Alcohol-related cirrhosis: The most challenging etiology of cirrhosis is more burdensome than ever
Marta Tonon, Salvatore Piano
Clin Mol Hepatol. 2021;27(1):94-96.   Published online December 3, 2020
View: 5287   Download: 147  Web of Science: 7  Crossref: 8
Review
1563
Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
Gwyneth Soon, Aileen Wee
Clin Mol Hepatol. 2021;27(1):44-57.   Published online November 19, 2020
View: 14454   Download: 380  Web of Science: 39  Crossref: 41
Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)
Emerging medical therapies for severe alcoholic hepatitis
David Tornai, Gyongyi Szabo
Clin Mol Hepatol. 2020;26(4):686-696.   Published online September 28, 2020
View: 7319   Download: 233  Web of Science: 20  Crossref: 20
Review
1510
Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis
Le Thi Thanh Thuy, Hoang Hai, Norifumi Kawada
Clin Mol Hepatol. 2020;26(3):280-293.   Published online June 4, 2020
View: 8915   Download: 241  Web of Science: 15  Crossref: 15
Original Article
Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients
Waleed Seif Eldin Mohamed Mostafa, Mohammed Hassan Saiem Al-Dahr, Dalia Abdel Hamid Omran, Zeinab Fathy Abdullah, Suzan Hamdy Elmasry, Mohamed Nabil Ibrahim
Clin Mol Hepatol. 2020;26(1):60-69.   Published online October 22, 2019
View: 6869   Download: 143  Web of Science: 5  Crossref: 5
Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
Hye Soo Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Young Nyun Park, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Gi Hong Choi, Hyon-Suk Kim
Clin Mol Hepatol. 2020;26(1):33-44.   Published online June 27, 2019
View: 6809   Download: 200  Web of Science: 21  Crossref: 17
Review
1449
Advances in ultrasound diagnosis in chronic liver diseases
Hitoshi Maruyama, Naoya Kato
Clin Mol Hepatol. 2019;25(2):160-167.   Published online February 18, 2019
View: 12147   Download: 488  Web of Science: 21  Crossref: 22
Original Article
1418
The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study
Laura Rotundo, Alana Persaud, Mirela Feurdean, Sushil Ahlawat, Hyun-seok Kim
Clin Mol Hepatol. 2018;24(4):392-401.   Published online August 2, 2018
View: 13212   Download: 247  Web of Science: 52  Crossref: 49
Characterization and evaluation of liver fibrosis grade in patients with chronic hepatitis B virus infection and normal transaminases
San Juan López Cristina, Casado Martín Marta, González Sánchez Mercedes, Porcel Martín Almudena, Hernández Martínez Álvaro, Vega Sáenz Jose Luis, Parrón Carreño Tesifón
Clin Mol Hepatol. 2018;24(4):384-391.   Published online July 4, 2018
View: 8638   Download: 203  Web of Science: 11  Crossref: 10
Editorial
Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase level
Mi Young Jeon, Beom Kyung Kim, Seung Up Kim
Clin Mol Hepatol. 2018;24(4):367-369.   Published online September 19, 2018
View: 7408   Download: 169  Web of Science: 4  Crossref: 4
Review
1401
Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend
Grace Lai-Hung Wong
Clin Mol Hepatol. 2018;24(2):108-113.   Published online January 22, 2018
View: 14473   Download: 519  Web of Science: 39  Crossref: 40
1396
Histopathological evaluation of liver fibrosis and cirrhosis regression
Regina C. Lo, Haeryoung Kim
Clin Mol Hepatol. 2017;23(4):302-307.   Published online December 20, 2017
View: 17360   Download: 555  Web of Science: 97  Crossref: 95
Liver Imaging
What we need to know when performing and interpreting US elastography
So Hyun Park, So Yeon Kim, Chong Hyun Suh, Seung Soo Lee, Kyoung Won Kim, So Jung Lee, Moon-Gyu Lee
Clin Mol Hepatol. 2016;22(3):406-414.   Published online September 25, 2016
View: 13734   Download: 285  Web of Science: 40  Crossref: 40
Original Article
1281
Magnetization-tagged MRI is a simple method for predicting liver fibrosis
Kyung-Eun Kim, Mi-Suk Park, Sohae Chung, Chansik An, Leon Axel, Rakhmonova Gulbahor Ergashovna
Clin Mol Hepatol. 2016;22(1):140-145.   Published online March 28, 2016
View: 9146   Download: 74  Web of Science: 1  Crossref: 1
Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis
Yoon Ok Jang, Baek Gyu Jun, Soon Koo Baik, Moon Young Kim, Sang Ok Kwon
Clin Mol Hepatol. 2015;21(2):141-149.   Published online June 26, 2015
View: 10015   Download: 141  Web of Science: 46  Crossref: 42
The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B
In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
Clin Mol Hepatol. 2015;21(1):32-40.   Published online March 25, 2015
View: 10259   Download: 90  Web of Science: 13  Crossref: 12
Editorial
Regression of liver cirrhosis: Orthodoxy or paradigm shift?
Su Jong Yu
Clin Mol Hepatol. 2015;21(1):22-23.   Published online March 25, 2015
View: 6929   Download: 91  Web of Science: 2  Crossref: 1
1 | 2 | 3 | 4 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 988
TOTAL : 2469067
Close layer